| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.94 | 0.003 | 0.94 | Epidermal growth factor receptor kinase inhibitor | 0.871 0.003 CID_16045730 | ||
| 0.884 | 0.003 | 0.884 | Epidermal growth factor antagonist | 0.79 0.003 CID_16045730 | ||
| 0.881 | 0.002 | 0.881 | ErbB-1 antagonist | 0.842 0.002 CID_16045730 | ||
| 0.861 | 0.004 | 0.861 | Growth factor antagonist | 0.772 0.005 CID_16045730 | ||
| 0.787 | 0.003 | 0.787 | ErbB-2 antagonist | 0.665 0.004 CID_16045730 | ||
| 0.688 | 0.005 | 0.688 | Vascular endothelial growth factor antagonist | 0.563 0.006 CID_16045730 | ||
| 0.665 | 0.005 | 0.665 | Vascular endothelial growth factor 2 antagonist | 0.539 0.006 CID_16045730 | ||
| 0.648 | 0.012 | 0.648 | Angiogenesis inhibitor | 0.588 0.018 CID_16045730 | ||
| 0.596 | 0.005 | 0.596 | RET inhibitor | 0.512 0.005 CID_16045730 | ||
| 0.526 | 0.004 | 0.526 | Ephrin antagonist | 0.463 0.005 CID_16045730 | ||
| 0.525 | 0.005 | 0.525 | Platelet activating factor beta antagonist | 0.432 0.005 CID_16045730 | ||
| 0.516 | 0.004 | 0.567 | MAP kinase kinase 2 inhibitor | 0.567 0.004 CID_16045730 | CID_16045730 | |
| 0.538 | 0.027 | 0.699 | Aldehyde oxidase inhibitor | 0.699 0.008 CID_16045730 | CID_16045730 | |
| 0.511 | 0.004 | 0.511 | ErbB-4 antagonist | 0.428 0.004 CID_16045730 | ||
| 0.49 | 0.01 | 0.49 | Platelet aggregation inhibitor | 0.453 0.013 CID_16045730 | ||
| 0.495 | 0.018 | 0.495 | Tyrosine kinase inhibitor | 0.372 0.031 CID_16045730 | ||
| 0.483 | 0.005 | 0.483 | Vascular endothelial growth factor 3 antagonist | 0.382 0.011 CID_16045730 | ||
| 0.471 | 0.007 | 0.471 | Src kinase inhibitor | 0.401 0.012 CID_16045730 | ||
| 0.45 | 0.003 | 0.45 | EphB4 antagonist | 0.386 0.003 CID_16045730 | ||
| 0.451 | 0.006 | 0.451 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.405 0.012 CID_16045730 | ||
| 0.449 | 0.005 | 0.449 | Platelet activating factor antagonist | 0.362 0.007 CID_16045730 | ||
| 0.418 | 0.004 | 0.486 | MAP kinase kinase inhibitor | 0.486 0.003 CID_16045730 | CID_16045730 | |
| 0.413 | 0.007 | 0.413 | c-Src kinase inhibitor | 0.362 0.01 CID_16045730 | ||
| 0.42 | 0.024 | 0.432 | DNA damaging | 0.432 0.022 CID_16045730 | CID_16045730 | |
| 0.397 | 0.003 | 0.397 | ErbB-3 antagonist | 0.344 0.004 CID_16045730 | ||
| 0.398 | 0.011 | 0.398 | DNA methylase inhibitor | 0.361 0.015 CID_16045730 | ||
| 0.393 | 0.008 | 0.393 | Protein-tyrosine kinase Lyn inhibitor | 0.328 0.015 CID_16045730 | ||
| 0.387 | 0.005 | 0.387 | Vascular endothelial growth factor 1 antagonist | 0.304 0.011 CID_16045730 | ||
| 0.39 | 0.015 | 0.39 | CDC-like kinase 4 inhibitor | 0.325 0.026 CID_16045730 | ||
| 0.38 | 0.023 | 0.38 | Clk dual-specificity kinase inhibitor | 0.301 0.038 CID_16045730 | ||
| 0.363 | 0.006 | 0.363 | Protein kinase (CK2) alpha inhibitor | 0.348 0.007 CID_16045730 | ||
| 0.346 | 0.005 | 0.346 | Raf kinase C inhibitor | 0.316 0.005 CID_16045730 | ||
| 0.334 | 0.004 | 0.334 | EphA2 antagonist | 0.304 0.004 CID_16045730 | ||
| 0.328 | 0.011 | 0.328 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.293 0.017 CID_16045730 | ||
| 0.316 | 0.002 | 0.316 | Fructose-1,6-bisphosphatase inhibitor | 0.308 0.002 CID_16045730 | ||
| 0.387 | 0.087 | 0.395 | 5 Hydroxytryptamine release inhibitor | 0.395 0.081 CID_16045730 | CID_16045730 | |
| 0.33 | 0.03 | 0.33 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.279 0.047 CID_16045730 | ||
| 0.313 | 0.015 | 0.313 | Lck kinase inhibitor | 0.261 0.022 CID_16045730 | ||
| 0.294 | 0.02 | 0.294 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.208 0.035 CID_16045730 | ||
| 0.275 | 0.01 | 0.275 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.208 0.017 CID_16045730 | ||
| 0.292 | 0.029 | 0.292 | DNA methyltransferase I inhibitor | 0.267 0.04 CID_16045730 | ||
| 0.265 | 0.005 | 0.265 | MAP kinase kinase 5 inhibitor | 0.256 0.005 CID_16045730 | ||
| 0.283 | 0.025 | 0.283 | LIM domain kinase 1 inhibitor | 0.245 0.04 CID_16045730 | ||
| 0.266 | 0.009 | 0.266 | Platelet activating factor alpha antagonist | 0.204 0.016 CID_16045730 | ||
| 0.264 | 0.01 | 0.264 | Protein kinase (CK2) inhibitor | 0.247 0.011 CID_16045730 | ||
| 0.277 | 0.037 | 0.277 | CDC-like kinase 2 inhibitor | 0.235 0.051 CID_16045730 | ||
| 0.247 | 0.01 | 0.247 | Breast cancer-resistant protein inhibitor | 0.197 0.014 CID_16045730 | ||
| 0.257 | 0.02 | 0.257 | Aurora-B kinase inhibitor | 0.197 0.032 CID_16045730 | ||
| 0.241 | 0.009 | 0.241 | Raf kinase inhibitor | 0.172 0.015 CID_16045730 | ||
| 0.236 | 0.004 | 0.251 | Fibroblast growth factor 2 antagonist | 0.251 0.004 CID_16045730 | CID_16045730 | |
| 0.246 | 0.016 | 0.246 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.162 0.03 CID_16045730 | ||
| 0.225 | 0.004 | 0.274 | MAP kinase kinase 1 inhibitor | 0.274 0.003 CID_16045730 | CID_16045730 | |
| 0.229 | 0.008 | 0.229 | Raf kinase B inhibitor | 0.153 0.013 CID_16045730 | ||
| 0.23 | 0.015 | 0.23 | Granulocyte macrophage colony stimulating factor antagonist | 0.194 0.023 CID_16045730 | ||
| 0.22 | 0.007 | 0.22 | Platelet growth factor antagonist | 0.172 0.013 CID_16045730 | ||
| 0.272 | 0.063 | 0.272 | Dyrk kinase inhibitor | 0.226 0.084 CID_16045730 | ||
| 0.346 | 0.141 | 0.357 | Apoptosis agonist | 0.357 0.135 CID_16045730 | CID_16045730 | |
| 0.256 | 0.054 | 0.256 | EphB2 antagonist | 0.212 0.08 CID_16045730 | ||
| 0.212 | 0.015 | 0.233 | Cyclooxygenase 3 inhibitor | 0.233 0.011 CID_16045730 | CID_16045730 | |
| 0.214 | 0.025 | 0.214 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.184 0.033 CID_16045730 | ||
| 0.213 | 0.025 | 0.213 | Abl kinase inhibitor | 0.183 0.033 CID_16045730 | ||
| 0.238 | 0.057 | 0.238 | Death-associated protein kinase 3 inhibitor | 0.183 0.086 CID_16045730 | ||
| 0.203 | 0.036 | 0.203 | Activin receptor-like kinase 2 inhibitor | 0.147 0.069 CID_16045730 | ||
| 0.182 | 0.018 | 0.182 | TIE antagonist | 0.123 0.03 CID_16045730 | ||
| 0.235 | 0.074 | 0.235 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.198 0.094 CID_16045730 | ||
| 0.23 | 0.068 | 0.23 | Antimitotic | 0.21 0.078 CID_16045730 | ||
| 0.178 | 0.017 | 0.178 | TIE-2 antagonist | 0.122 0.029 CID_16045730 | ||
| 0.211 | 0.054 | 0.211 | Growth factor agonist | 0.208 0.056 CID_16045730 | ||
| 0.173 | 0.017 | 0.173 | Multidrug resistance-associated protein 1 inhibitor | 0.146 0.027 CID_16045730 | ||
| 0.181 | 0.03 | 0.181 | Aurora-A kinase inhibitor | 0.147 0.041 CID_16045730 | ||
| 0.163 | 0.027 | 0.163 | Fibroblast growth factor 1 antagonist | 0.144 0.033 CID_16045730 | ||
| 0.307 | 0.173 | 0.319 | MAP kinase 1 inhibitor | 0.319 0.16 CID_16045730 | CID_16045730 | |
| 0.179 | 0.049 | 0.179 | CDC-like kinase 1 inhibitor | 0.16 0.063 CID_16045730 | ||
| 0.132 | 0.002 | 0.132 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.132 0.002 CID_16045730 | ||
| 0.165 | 0.036 | 0.175 | Aurora-C kinase inhibitor | 0.175 0.029 CID_16045730 | CID_16045730 | |
| 0.174 | 0.051 | 0.174 | Glycogen synthase kinase-3 alpha inhibitor | 0.131 0.078 CID_16045730 | ||
| 0.236 | 0.113 | 0.236 | Hypoxia-inducible factor 1 alpha inhibitor | 0.196 0.156 CID_16045730 | ||
| 0.137 | 0.02 | 0.137 | Bcr-Abl kinase inhibitor | 0.108 0.034 CID_16045730 | ||
| 0.154 | 0.045 | 0.154 | TRKB antagonist | 0.118 0.075 CID_16045730 | ||
| 0.132 | 0.03 | 0.132 | CDC-like kinase 3 inhibitor | 0.131 0.031 CID_16045730 | ||
| 0.13 | 0.028 | 0.13 | Insulin growth factor antagonist | 0.114 0.038 CID_16045730 | ||
| 0.181 | 0.079 | 0.181 | TRKC antagonist | 0.135 0.115 CID_16045730 | ||
| 0.125 | 0.023 | 0.125 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.097 0.037 CID_16045730 | ||
| 0.154 | 0.054 | 0.161 | MAP3K9 inhibitor | 0.161 0.045 CID_16045730 | CID_16045730 | |
| 0.119 | 0.02 | 0.119 | Glutamate (mGluR group I) antagonist | 0.084 0.034 CID_16045730 | ||
| 0.123 | 0.028 | 0.123 | Insulin like growth factor 1 antagonist | 0.105 0.038 CID_16045730 | ||
| 0.103 | 0.014 | 0.103 | Phosphodiesterase 1B inhibitor | 0.075 0.027 CID_16045730 | ||
| 0.18 | 0.092 | 0.18 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.17 0.101 CID_16045730 | ||
| 0.112 | 0.024 | 0.12 | Purinergic P2X2 antagonist | 0.12 0.021 CID_16045730 | CID_16045730 | |
| 0.113 | 0.032 | 0.113 | Phosphodiesterase I inhibitor | 0.093 0.053 CID_16045730 | ||
| 0.108 | 0.028 | 0.108 | Fibroblast growth factor 3 antagonist | 0.106 0.029 CID_16045730 | ||
| 0.109 | 0.03 | 0.109 | Glutamate (mGluR) antagonist | 0.078 0.051 CID_16045730 | ||
| 0.091 | 0.014 | 0.091 | Heat shock protein 90 beta antagonist | 0.076 0.024 CID_16045730 | ||
| 0.15 | 0.073 | 0.15 | GABA C receptor rho-2 antagonist | |||
| 0.109 | 0.037 | 0.116 | Polo-like kinase-1 inhibitor | 0.116 0.032 CID_16045730 | CID_16045730 | |
| 0.139 | 0.068 | 0.139 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.108 0.093 CID_16045730 | ||
| 0.186 | 0.122 | 0.2 | RNA-directed DNA polymerase inhibitor | 0.2 0.099 CID_16045730 | CID_16045730 | |
| 0.094 | 0.031 | 0.094 | Transforming growth factor beta 3 antagonist | 0.094 0.031 CID_16045730 | ||
| 0.093 | 0.03 | 0.093 | Vanilloid 1 antagonist | 0.075 0.04 CID_16045730 | ||
| 0.077 | 0.014 | 0.077 | Glutamate (mGluR5) antagonist | 0.05 0.029 CID_16045730 | ||
| 0.094 | 0.031 | 0.102 | Syk tyrosine kinase inhibitor | 0.102 0.027 CID_16045730 | CID_16045730 | |
| 0.086 | 0.027 | 0.086 | MAP kinase 7 inhibitor | 0.079 0.048 CID_16045730 | ||
| 0.084 | 0.029 | 0.085 | ZAP-70 protein tyrosine kinase inhibitor | 0.085 0.029 CID_16045730 | CID_16045730 | |
| 0.07 | 0.02 | 0.07 | Proto-oncogene tyrosine-protein kinase Met inhibitor | 0.051 0.031 CID_16045730 | ||
| 0.09 | 0.04 | 0.09 | Vanilloid antagonist | 0.068 0.059 CID_16045730 | ||
| 0.094 | 0.045 | 0.094 | AXL receptor tyrosine kinase inhibitor | |||
| 0.086 | 0.041 | 0.086 | Protein kinase B gamma inhibitor | 0.072 0.054 CID_16045730 | ||
| 0.179 | 0.134 | 0.179 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.148 | 0.104 | 0.148 | Tumour necrosis factor antagonist | |||
| 0.082 | 0.039 | 0.082 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.066 0.058 CID_16045730 | ||
| 0.055 | 0.012 | 0.082 | Phosphoglycerate kinase inhibitor | 0.082 0.008 CID_16045730 | CID_16045730 | |
| 0.09 | 0.048 | 0.09 | ALK inhibitor | 0.077 0.063 CID_16045730 | ||
| 0.103 | 0.06 | 0.103 | Cyclin-dependent kinase 9 inhibitor | 0.102 0.061 CID_16045730 | ||
| 0.158 | 0.118 | 0.158 | Focal adhesion kinase 2 inhibitor | |||
| 0.083 | 0.046 | 0.083 | Focal adhesion kinase 1 inhibitor | |||
| 0.059 | 0.023 | 0.059 | Antiviral (Hepatitis D) | 0.053 0.031 CID_16045730 | ||
| 0.16 | 0.125 | 0.16 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.157 0.133 CID_16045730 | ||
| 0.136 | 0.101 | 0.186 | Polo-like kinase-3 inhibitor | 0.186 0.053 CID_16045730 | CID_16045730 | |
| 0.086 | 0.053 | 0.086 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.064 | 0.033 | 0.064 | Fibroblast growth factor 4 antagonist | 0.063 0.034 CID_16045730 | ||
| 0.115 | 0.085 | 0.115 | Tubulin antagonist | |||
| 0.04 | 0.011 | 0.045 | Estrogen-related receptor beta antagonist | 0.045 0.008 CID_16045730 | CID_16045730 | |
| 0.066 | 0.039 | 0.066 | Adenosine A2a receptor antagonist | |||
| 0.063 | 0.036 | 0.063 | CDK9/cyclin T1 inhibitor | 0.058 0.042 CID_16045730 | ||
| 0.042 | 0.015 | 0.056 | Purinergic P2X3 antagonist | 0.056 0.009 CID_16045730 | CID_16045730 | |
| 0.103 | 0.077 | 0.103 | Glycogen synthase kinase-3 inhibitor | |||
| 0.096 | 0.07 | 0.096 | MAP kinase kinase kinase inhibitor | |||
| 0.095 | 0.069 | 0.095 | Check point kinase 2 inhibitor | |||
| 0.101 | 0.076 | 0.101 | Glycogen synthase kinase-3 beta inhibitor | |||
| 0.115 | 0.091 | 0.115 | Tyrosine-protein kinase receptor antagonist | |||
| 0.107 | 0.083 | 0.107 | Interleukin 8 antagonist | 0.102 0.092 CID_16045730 | ||
| 0.045 | 0.023 | 0.059 | Thymidine kinase inhibitor | 0.059 0.014 CID_16045730 | CID_16045730 | |
| 0.031 | 0.01 | 0.032 | Adenosine kinase inhibitor | 0.032 0.009 CID_16045730 | CID_16045730 | |
| 0.077 | 0.056 | 0.08 | MAP kinase kinase 7 inhibitor | 0.08 0.045 CID_16045730 | CID_16045730 | |
| 0.082 | 0.061 | 0.087 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.087 0.053 CID_16045730 | CID_16045730 | |
| 0.123 | 0.103 | 0.123 | CC chemokine 6 receptor antagonist | 0.121 0.113 CID_16045730 | ||
| 0.193 | 0.176 | 0.209 | Transcription factor NF kappa B inhibitor | 0.209 0.16 CID_16045730 | CID_16045730 | |
| 0.074 | 0.058 | 0.112 | Keratolytic | 0.112 0.024 CID_16045730 | CID_16045730 | |
| 0.084 | 0.07 | 0.084 | Hepatocyte growth factor antagonist | 0.081 0.073 CID_16045730 | ||
| 0.03 | 0.015 | 0.032 | DNA polymerase III inhibitor | 0.032 0.012 CID_16045730 | CID_16045730 | |
| 0.064 | 0.051 | 0.07 | Potassium channel (ATP-sensitive) blocker | 0.07 0.041 CID_16045730 | CID_16045730 | |
| 0.028 | 0.017 | 0.028 | Glucosylceramidase stimulant | |||
| 0.07 | 0.059 | 0.07 | Adenosine A3 receptor antagonist | |||
| 0.027 | 0.017 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.028 0.015 CID_16045730 | CID_16045730 | |
| 0.086 | 0.079 | 0.086 | Toll-Like receptor 3 antagonist | |||
| 0.051 | 0.046 | 0.051 | Bruton tyrosine kinase inhibitor | |||
| 0.086 | 0.083 | 0.086 | Insulin receptor antagonist | |||
| 0.204 | 0.202 | 0.204 | GABA C receptor rho-3 antagonist | |||
| 0.071 | 0.069 | 0.074 | Sphingosine 1-phosphate receptor antagonist | 0.074 0.059 CID_16045730 | CID_16045730 | |
| 0.021 | 0.02 | 0.024 | Adenosine A1 receptor agonist | 0.024 0.017 CID_16045730 | CID_16045730 | |
| 0.012 | 0.015 | 0.013 | DNA polymerase III polC-type inhibitor | 0.013 0.01 CID_16045730 | CID_16045730 | |
| 0.049 | 0.059 | 0.052 | Sphingosine 1-phosphate receptor 1 antagonist | 0.052 0.047 CID_16045730 | CID_16045730 | |
| 0.071 | 0.099 | 0.086 | Aminoacyl-tRNA synthetase inhibitor | 0.086 0.065 CID_16045730 | CID_16045730 | |
| 0.079 | 0.121 | 0.106 | Alkylator | 0.106 0.081 CID_16045730 | CID_16045730 | |
| 0.125 | 0.182 | 0.144 | Catenin beta inhibitor | 0.144 0.12 CID_16045730 | CID_16045730 | |
| 0.158 | 0.263 | 0.203 | Toll-Like receptor agonist | 0.203 0.198 CID_16045730 | CID_16045730 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |